Historical record - last NADAC effective date: 6/17/2015
Product Information
AMLODIPINE-BENAZEPRIL 5-20 MG is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $0.3238 per EA under NDC 68180075702. Its NADAC has been published 86 times since Nov 28, 2013.
FDA first approved this application on Feb 5, 2010. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5; 20 mg/1; mg/1
Manufacturer
Lupin Pharmaceuticals Inc.NDC
68180075702
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
6/17/2015
Active Ingredients
AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA078466FDA Approved
2/5/2010
TE Code
AB
On Market Since
2/5/2010
Pharmacological Classes
Price Statistics
The NADAC for AMLODIPINE-BENAZEPRIL 5-20 MG has been published 86 times since Nov 28, 2013, and over the history we have for it it has declined 31.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3238 per EA |
|---|---|
| All-time high | $0.4743 (Dec 11, 2013) |
| All-time low | $0.3238 (Jun 17, 2015) |
| Median price | $0.3657 |
| Average price | $0.3763 |
| Largest weekly change | -17.1% (Feb 18, 2015) |
| Weeks tracked | 86 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
-31.7%
Last surveyed Jul 15, 2015 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 68% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of AMLODIPINE-BENAZEPRIL 5-20 MG?
The current National Average Drug Acquisition Cost (NADAC) for AMLODIPINE-BENAZEPRIL 5-20 MG, manufactured by Lupin Pharmaceuticals Inc., is $0.3238 per EA (NDC 68180075702), effective Jul 15, 2015.
How has the price of AMLODIPINE-BENAZEPRIL 5-20 MG changed over time?
Over the history we have for it, the NADAC for AMLODIPINE-BENAZEPRIL 5-20 MG has declined 31.7%. It has been tracked across 86 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for AMLODIPINE-BENAZEPRIL 5-20 MG?
Since Nov 28, 2013, the NADAC for AMLODIPINE-BENAZEPRIL 5-20 MG has ranged from a low of $0.3238 (Jun 17, 2015) to a high of $0.4743 (Dec 11, 2013), with a median of $0.3657 per EA.
Are there cheaper alternatives to AMLODIPINE-BENAZEPRIL 5-20 MG?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, AMLODIPINE-BENAZEPRIL 5-20 MG, is $0.1036 per EA — about 68% below AMLODIPINE-BENAZEPRIL 5-20 MG.
Who manufactures AMLODIPINE-BENAZEPRIL 5-20 MG?
AMLODIPINE-BENAZEPRIL 5-20 MG (NDC 68180075702) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.